15,612
edits
Changes
Jump to navigation
Jump to search
m
EMLA
,Wikify.
}}</ref>
In June 2013, the use of EMLA® ointment in neonatal [[circumcision ]] was deemed “ethically unacceptable” by the CMDh group at the EMA.<ref>{{REFweb
|url=http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Paediatric_Regulation/Assessment_Reports/Article_45_work-sharing/Lidocaine_2013_07_45_PdAR.pdf
|title=Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Cathejell Lidocaine, Dynexan, EMLA, Jelliproct, Orofar, Strepsil lus, Xylestesin-A, Xylonor (Lidocaine)
}}</ref>
Various studies come to the conclusion that EMLA-circumcisions of young children are not suitable to sufficiently exclude the [[pain]].<ref>{{REFjournal
|title=Does topical Amethocaine cream increase first-Time successful cannulation in children compared with a eutectic mixture of local anaesthetics (EMLA) cream? A systematic review and meta-analysis of randomised controlled trials
|url=https://www.researchgate.net/publication/267728942